• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2101070 重组人促红素-β注射液(CHO细胞) Recombinant Human Erythropoietin β(CHO Cell) Injection Biological Products Supplementary Application 2021-06-30 Roche Diagnostics GmbH;Roche Pharma (Schweiz) Ltd view
CYSB2400064 人促红素注射液 Human Erythropoietin Injection Biological Products Supplementary Application 2024-03-09 Shenyang Sunshine Pharmaceutical Co Ltd;Nmv Desen Biotech Co Ltd view
JXSS1300007 甲氧聚二醇重组人促红素注射液 Injection Biological Products Import Drug Application 2013-06-18 Roche Diagnostics GmbH;Roche Pharma (Schweiz) Ltd Certificate Issued 2018-05-24 view
CYSB2101009 重组人促红素注射液(CHO细胞) Human Erythropoietin Injection Biological Products Supplementary Application 2021-03-22 Beijing Four Rings Bio-Pharmaceutical Co Ltd view
JXSL1000030 甲氧聚二醇重组人促红素注射液 Injection Biological Products Import Drug Application 2010-08-04 Roche Pharma (Schweiz) Ltd Certificate Issued 2013-02-19 view
JYSB2300071 甲氧聚二醇重组人促红素注射液 Injection Biological Products Supplementary Application 2023-04-26 Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG view
JYSB2200127 人促红素注射液 Human Erythropoietin Injection Biological Products Supplementary Application 2022-07-14 Nichi-Iko Gifu Plant Co Ltd;Kyowa Hakko Kirin Co Ltd view
J0401452 重组人红细胞生成素-beta 注射液 Injection Biological Products Supplementary Application 2004-08-12 Shanghai Roche Pharmaceuticals Ltd Beijing Certificate Issued 2005-05-09 view
JYSB2101197 重组人促红素-β注射液(CHO细胞) Recombinant Human Erythropoietin β(CHO Cell) Injection Biological Products Supplementary Application 2021-12-17 Roche Diagnostics GmbH;Roche Pharma (Schweiz) Ltd view
CYSB2400178 人促红素注射液 Human Erythropoietin Injection Biological Products Supplementary Application 2024-07-09 Shenyang Sunshine Pharmaceutical Co Ltd view
CYSB2200215 人促红素注射液 Human Erythropoietin Injection Biological Products Supplementary Application 2022-08-26 Shenyang Sunshine Pharmaceutical Co Ltd view
CYSB2200076 人促红素注射液 Human Erythropoietin Injection Biological Products Supplementary Application 2022-03-10 Kexing Biopharm Co Ltd view
JYSZ2200045 甲氧聚二醇重组人促红素注射液 Injection Biological Products License Renew 2022-08-30 Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG;Roche (China) Holding Ltd view
CYSB2400204 人促红素注射液 Human Erythropoietin Injection Biological Products Supplementary Application 2024-08-08 NCPC Genetech BIOTECHNOLOGY Co Ltd view
CXSS2101070 人促红素注射液 Human Erythropoietin Injection Biological Products(3.4) New Drug Application 2021-12-22 Shanghai Chemo Wanbang Biophama Co Ltd view
JYSB2300072 甲氧聚二醇重组人促红素注射液 Injection Biological Products Supplementary Application 2023-04-26 Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG view
JXSS1300003 甲氧聚二醇重组人促红素注射液 Injection Biological Products Import Drug Application 2013-06-18 Roche Diagnostics GmbH;Roche Pharma (Schweiz) Ltd Certificate Issued 2014-06-10 view
CYSB2101015 重组人促红素注射液(CHO细胞) Human Erythropoietin Injection Biological Products Supplementary Application 2021-03-22 Beijing Four Rings Bio-Pharmaceutical Co Ltd view
JXSL1000034 甲氧聚二醇重组人促红素注射液 Injection Biological Products Import Drug Application 2010-08-04 Roche Pharma (Schweiz) Ltd Certificate Issued 2013-02-19 view
CXSB2300012 聚乙二醇重组人促红素注射液 Injection Biological Products(1) Supplementary Application 2023-02-03 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd view